AI Summary

The Substance Use Disorders Harm Reduction Act aims to address substance use disorders through harm reduction strategies. The bill focuses on improving access to evidence-based treatments, reducing overdose deaths, and promoting harm reduction practices. It includes provisions such as expanding access to naloxone, supporting syringe exchange programs, and enhancing education on safe injection practices. The bill seeks to mitigate the negative impacts of substance use disorders by emphasizing harm reduction approaches and increasing support for individuals affected by addiction.

• 2024-01-10: Introduced In House - Assigned to Health & Human Services

• 2024-02-20: House Committee on Health & Human Services Refer Amended to House Committee of the Whole

• 2024-02-23: House Second Reading Laid Over Daily - No Amendments

• 2024-03-01: House Second Reading Special Order - Passed with Amendments - Committee, Floor

• 2024-03-04: House Third Reading Passed - No Amendments

• 2024-03-07: Introduced In Senate - Assigned to Health & Human Services

• 2024-03-27: Senate Committee on Health & Human Services Refer Unamended to Senate Committee of the Whole

• 2024-04-02: Senate Second Reading Passed with Amendments - Floor

• 2024-04-03: Senate Third Reading Passed - No Amendments

• 2024-04-04: House Considered Senate Amendments - Result was to Laid Over Daily

• 2024-04-19: House Considered Senate Amendments - Result was to Not Concur - Request Conference Committee

• 2024-04-29: First Conference Committee Result was to Adopt Rerevised w/ Amendments

• 2024-04-30: Senate Consideration of First Conference Committee Report result was to Adopt Committee Report - Repass

• 2024-05-04: House Consideration of First Conference Committee Report result was to Adopt Committee Report - Repass

• 2024-05-23: Signed by the Speaker of the House

• 2024-05-23: Signed by the President of the Senate

• 2024-05-23: Sent to the Governor

• 2024-06-06: Governor Signed